Prevention & lipids

Influence of Subclinical Atherosclerosis Burden and Progression on Mortality

J Am Coll CardiolPublished Prospective cohort study

Authors' conclusion

Subclinical atherosclerosis burden (cPB and CAC) in asymptomatic individuals was independently associated with all-cause mortality. Moreover, atherosclerosis progression was independently associated with all-cause mortality.

Study context

Population
Asymptomatic US adults (mean age 68.9 years, 56.7% female), BioImage study, enrolled 2008–2009732 with follow-up ultrasound
Participants
5,716 adults
Outcome
All-cause mortality
Follow-up
Median 12.4 years'

Main finding

As reported in the abstract

median 12.4 years
Estimate (95% CI)P value
cPBbaseline cPB, per-tertile increase
fully adjusted trend HR 1.23(1.16–1.32)
P < 0.001
CAC scorebaseline CAC score, per-tertile increase
HR 1.15(1.08–1.23)
P < 0.001

Per-tertile increase, as printed

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)P value
cPB progression and all-cause mortality · follow-up ultrasound median 8.9 years after baselineAdjusted for CV risk factors and baseline cPB1.03 (1.01–1.04)P = 0.01
  • Carotid plaque burden (cPB) progression and all-cause mortality: 732 participants with second ultrasound

cPB progression and all-cause mortality · follow-up ultrasound median 8.9 years after baseline

Median cPB progressed from 29.2 to 91.3 mm³

Original publication

Influence of Subclinical Atherosclerosis Burden and Progression on Mortality. J Am Coll Cardiol. Published 8 October 2024. doi:10.1016/j.jacc.2024.06.045

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.